Anika Therapeutics, Inc.
ANIKCIK 0000898437 · Every Form 4 filed by insiders at this issuer.
Filings
6
Latest Mar 19, 2024
Unique insiders
3
Showing
6 of 6
Page 1
Top insiders
Most active reporters at Anika Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Blanchard Cheryl R | OfficerDirector | 2 |
| Colleran David | Officer | 2 |
| Levitz Michael L | Officer | 2 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 19, 2024 | Blanchard Cheryl R President, CEO, Director · Director | Holdings only | — | — | — | |
| Mar 19, 2024 | Colleran David EVP, General Counsel, Corp Sec | Holdings only | — | — | — | |
| Mar 19, 2024 | Levitz Michael L EVP, CFO, Treasurer | Holdings only | — | — | — | |
| Mar 12, 2024 | Levitz Michael L EVP, CFO, Treasurer | F | 2,610 | $25.79 | $67,312 | |
| Mar 12, 2024 | Colleran David EVP, General Counsel, Corp Sec | F | 2,250 | $25.79 | $58,028 | |
| Mar 12, 2024 | Blanchard Cheryl R President, CEO, Director · Director | F | 14,534 | $25.79 | $374,832 |
Showing 1–6 of 6
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.